Is my portfolio
One Report to Answer all your Questions!
Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
909.85
7.70 (0.85%) Zydus Lifesciences - Quaterly Results
Date: 10-02-2026
The sales declined to Rs. 22836.00 millions for the December 2025 quarter as compared to Rs. 25159.00 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 2965.00 millions from Rs. 4706.00 millions, a decline of -37.00% on QoQ basis.Operating Profit reported a sharp decline to 6728.00 millions from 7260.00 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202512 | 202412 | % Var | 202512 | 202412 | % Var | 202503 | 202403 | % Var | |
| Sales | 22836.00 | 25159.00 | -9.23 | 77431.00 | 92967.00 | -16.71 | 151163.00 | 108187.00 | 39.72 |
| Other Income | 4738.00 | 775.00 | 511.35 | 15682.00 | 5654.00 | 177.36 | 9058.00 | 11595.00 | -21.88 |
| PBIDT | 6728.00 | 7260.00 | -7.33 | 31087.00 | 44744.00 | -30.52 | 84325.00 | 51435.00 | 63.94 |
| Interest | 1160.00 | 972.00 | 19.34 | 3674.00 | 3085.00 | 19.09 | 4639.00 | 3907.00 | 18.74 |
| PBDT | 4967.00 | 6288.00 | -21.01 | 26812.00 | 41659.00 | -35.64 | 79686.00 | 47442.00 | 67.97 |
| Depreciation | 1443.00 | 1316.00 | 9.65 | 4103.00 | 3959.00 | 3.64 | 5239.00 | 5044.00 | 3.87 |
| PBT | 3524.00 | 4972.00 | -29.12 | 22709.00 | 37700.00 | -39.76 | 74447.00 | 42398.00 | 75.59 |
| TAX | 559.00 | 266.00 | 110.15 | 4331.00 | 8088.00 | -46.45 | 16698.00 | 7983.00 | 109.17 |
| Deferred Tax | -259.00 | 508.00 | -150.98 | -200.00 | 528.00 | -137.88 | 873.00 | -1360.00 | -164.19 |
| PAT | 2965.00 | 4706.00 | -37.00 | 18378.00 | 29612.00 | -37.94 | 57749.00 | 34415.00 | 67.80 |
| Equity | 1006.00 | 1006.00 | 0.00 | 1006.00 | 1006.00 | 0.00 | 1006.00 | 1006.00 | 0.00 |
| PBIDTM(%) | 29.46 | 28.86 | 2.10 | 40.15 | 48.13 | -16.58 | 55.78 | 47.54 | 17.33 |